Hostname: page-component-7c8c6479df-5xszh Total loading time: 0 Render date: 2024-03-29T17:07:23.629Z Has data issue: false hasContentIssue false

Characterization of Transformants Obtained From NDM-1–Producing Enterobacteriaceae in Brazil

Published online by Cambridge University Press:  07 March 2017

Franciéli P. Rozales*
Affiliation:
Laboratório de Pesquisa em Resistência Bacteriana (LABRESIS), Centro de Pesquisa Experimental, Hospital de Clínicas de Porto Alegre (HCPA), Porto Alegre, Brazil Programa de Pós-Graduação em Ciências Farmacêuticas, Faculdade de Farmácia, Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, Brazil
Cibele M. Magagnin
Affiliation:
Laboratório de Pesquisa em Resistência Bacteriana (LABRESIS), Centro de Pesquisa Experimental, Hospital de Clínicas de Porto Alegre (HCPA), Porto Alegre, Brazil
Juliana C. Campos
Affiliation:
Universidade de São Paulo (USP), São Paulo, Brazil
Mariana Pagano
Affiliation:
Laboratório de Pesquisa em Resistência Bacteriana (LABRESIS), Centro de Pesquisa Experimental, Hospital de Clínicas de Porto Alegre (HCPA), Porto Alegre, Brazil
Luciana S. Nunes
Affiliation:
Laboratório de Pesquisa em Resistência Bacteriana (LABRESIS), Centro de Pesquisa Experimental, Hospital de Clínicas de Porto Alegre (HCPA), Porto Alegre, Brazil Curso de Medicina, Universidade Federal do Pampa, Uruguaiana, Brazil
Lisiane R. Pancotto
Affiliation:
Laboratório de Pesquisa em Resistência Bacteriana (LABRESIS), Centro de Pesquisa Experimental, Hospital de Clínicas de Porto Alegre (HCPA), Porto Alegre, Brazil
Jorge L. M. Sampaio
Affiliation:
Universidade de São Paulo (USP), São Paulo, Brazil
Alexandre P. Zavascki
Affiliation:
Laboratório de Pesquisa em Resistência Bacteriana (LABRESIS), Centro de Pesquisa Experimental, Hospital de Clínicas de Porto Alegre (HCPA), Porto Alegre, Brazil Infectious Diseases Service, Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil.
Afonso L. Barth
Affiliation:
Laboratório de Pesquisa em Resistência Bacteriana (LABRESIS), Centro de Pesquisa Experimental, Hospital de Clínicas de Porto Alegre (HCPA), Porto Alegre, Brazil Programa de Pós-Graduação em Ciências Farmacêuticas, Faculdade de Farmácia, Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, Brazil
*
Address correspondence to Franciéli Pedrotti Rozales, MsC, Laboratório de Pesquisa em Resistência Bacteriana (LABRESIS), Hospital de Clínicas de Porto Alegre, Ramiro Barcelos 2350, Porto Alegre, Brazil (frozales@hotmail.com).
Rights & Permissions [Opens in a new window]

Abstract

Type
Letters to the Editor
Copyright
© 2017 by The Society for Healthcare Epidemiology of America. All rights reserved 

To the Editor—The emergence of carbapenemase-producing Enterobacteriaceae (CPE) is an important public health problem because the treatment of CPE is difficult; few options remain available for clinical use.Reference Nordmann, Cuzon and Naas 1 The New Delhi metallo-β-lactamase (NDM-1) is the most common class B carbapenemase among Enterobacteriaceae, and it has been detected increasingly frequently in several countries,Reference Johnson and Woodford 2 including Brazil.Reference Carvalho-Assef, Pereira and Albano 3 Reference Carvalho-Assef, Pereira and Albano 8 The aim of this study was to evaluate the characteristics of transformants obtained from NDM-1–production in different bacterial species of Enterobacteriaceae identified in southern Brazil.

Isolates were selected from a surveillance study that evaluated Enterobacteriaceae with reduced susceptibility to carbapenems in Rio Grande do Sul State, southern Brazil. A total of 9 clinical NDM-producing isolates from 4 hospitals were selected for this study: 3 Klebsiella oxytoca, 2 Enterobacter clocae complex, 1 Klebsiella pneumoniae, 1 Morganella morganii, 1 Escherichia coli, and 1 Citrobacter freundii. These isolates were initially identified by the VITEK2 system (bioMèrieux, Marcy-l'Étoile, France) and confirmed by 16S rRNA sequencing. The bla NDM gene was detected by a multiplex real-time polymerase chain reaction (PCR), which also included primers for the bla KPC, bla VIM, bla GES, bla NDM, bla OXA-48, and bla IMP genes.Reference Quiles, Rocchetti and Fehlberg 9 The presence of bla NDM was further confirmed by conventional PCR, and the amplicons were purified and sequenced using a BigDye Terminator Kit (version 3.1, Thermo Fisher Scientific, Waltham, MA) and an ABI 3500 Genetic Analyzer (Applied Biosystems, Foster City, CA). GenBank was used to access the bla NDM sequences deposited to date, and the BioEdit program was used to compare similarities between sequences. The plasmids were extracted by alkaline lysis and were transformed into E. coli TOP10 electrocompetent cells by electroporation. Transformants were selected on Luria-Bertani agar containing 2 µg/mL ceftazidime. The transformants were evaluated for the bla NDM gene by conventional PCR with specific primers. The minimum inhibitory concentrations (MICs) of imipenem, meropenem, doripenem, piperacillin/tazobactam, ceftriaxone, cefepime, aztreonam, gentamicin, amikacin, polymyxin, and tigecycline were assessed by Etest (bioMèrieux, Marcy-l'Étoile, France). The modified Hodge test (MHT) and the combination-disc test (ie, meropenem and imipenem with and without ethylenediaminetetraacetic acid [EDTA]) were used as phenotypic methods for carbapenemase and metallo-β-lactamase detection, respectively.

It was possible to obtain transformants from all 9 clinical isolates. The transformants obtained from each isolate presented higher MICs than the original E. coli TOP10 for β-lactams. In fact, the MICs of transformants were similar to those of the donor NDM-positive clinical isolates, which showed high levels of resistance (Table 1).

TABLE 1 Phenotypic Characterization of Isolates and Transformants Obtained From NDM-1–Producers in Brazil

NOTE. T, transformant; MHT, modified Hodge test; EDTA, ethylenediaminetetraacetic acid; Neg, negative; Pos, positive; NA, not applicable; IMP, imipenem; MEM, meropenem; ERT, ertapenem; PTZ, piperacillin/tazobactam; CRO, ceftriaxone; CPM, cefepime; AZT, aztreonam; GEN, gentamicin; AMK, amikacin; POL, polymyxin B; TGC, tigecycline.

Notably, the combined-disc assay with EDTA proved to be positive (ie, EDTA inhibited the carbapenem activity) for all NDM-1–producing clinical isolates and transformants.

Plasmid analysis indicated that most transformants contained a 110-kb plasmid: 2 from the E. clocae complex and 1 each from K. oxytoca, M. morganii, E. coli, and C. freundii. However, it was also possible to identify the presence of a 52-kb plasmid in a transformant from K. oxytoca, a 154-kb plasmid from a K. oxytoca, and a K. pneumoniae (Table 1).

The in vitro transfer of plasmids containing the bla NDM-1 gene in our study confirms that this carbapenemase gene can be readily mobilized among different species of Enterobacteriaceae. Moreover, E. coli TOP10 transformants containing the bla NDM-1 gene presented similar characteristics of the original clinical isolate, with increased MIC to β-lactams and positive results of the combined-disc assay with EDTA. Although a plasmid of the same molecular weight (~110 bp) was observed in 6 of 9 transformants, the identification of other plasmids (~52 bp and ~154 bp) suggests that the bla NDM-1 gene is located in different mobile genetic elements.

Molecular investigations involving both the characterization of isolates of NDM-positive bacteria and the characterization of the plasmids containing bla NDM-1 genes reveal a highly complex picture. The plasmids encoding NDM also appear highly heterogeneous based on molecular size, incompatibility type, and linked antibiotic-resistance genes.Reference Johnson and Woodford 2 Moreover, our data support the findings from Brazil in which a variety of plasmids were found. The gene bla NDM-1 was identified on plasmid with an estimated size of 420–490 kb in Enterobacter hormaechei.Reference Carvalho-Assef, Pereira and Albano 8 In Enterobacter cloacae, Providencia rettgeri, and Klebsiella pneumoniae, the plasmid was reported to be ~230 kb.Reference Quiles, Rocchetti and Fehlberg 9 Escherichia coli and Enterobacter hormaechei had plasmid sizes of 70 kb and 90 kb, respectively.Reference Campos, da Silva and Dos Santos 10 The plasmid size in Acinetobacter baumannii was 100 kb.Reference Pillonetto, Arend and Vespero 7

In summary, the results of this study demonstrate the variety of plasmids observed in the transformants and suggests that strains producing bla NDM-1 harbor plasmids of different sizes, demonstrating the plasticity of these mobile genetic elements. These findings highlight the need for continuous monitoring of the presence of carbapenemases. Our results contribute to the understanding of carbapenem resistance in Enterobacteriaceae and to the molecular characterization of NDM-1–producing isolates in Brazil.

ACKNOWLEDGMENTS

Financial support: CAPES Foundation, Ministry of Education of Brazil, Brasília, Brazil. FIPE/HCPA (Research and Events Support Fund at Hospital de Clínicas de Porto Alegre). A.L.B. is a research fellow from the CNPq, Ministry of Science and Technology, Brazil (grant no. 458489/2014-0).

Potential conflicts of interest: All authors report no conflicts of interest relevant to this article.

References

REFERENCES

1. Nordmann, P, Cuzon, G, Naas, T. The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria. Lancet Infect Dis 2009;9:228236.Google Scholar
2. Johnson, AP, Woodford, N. Global spread of antibiotic resistance: the example of New Delhi metallo-β-lactamase (NDM)-mediated carbapenem resistance. J Med Microbiol 2013;62:499513.Google Scholar
3. Carvalho-Assef, AP, Pereira, PS, Albano, RM, et al. Isolation of NDM-producing Providencia rettgeri in Brazil. J Antimicrob Chemother 2013;68:29562957.Google Scholar
4. Rozales, FP, Ribeiro, VB, Magagnin, CM, et al. Emergence of NDM-1-producing Enterobacteriaceae in Porto Alegre, Brazil. Int J Infect Dis 2014;25:7981.Google Scholar
5. do Carmo Junior, NV, Filho, HF, Gomes, E, Costa, DA, et al. First report of a NDM-producing Providencia rettgeri strain in the state of São Paulo. Braz J Infect Dis 2015;19:675676.CrossRefGoogle ScholarPubMed
6. Pagano, M, Poirel, L, Martins, AF, et al. Emergence of NDM-1-producing Acinetobacter pittii in Brazil. Int J Antimicrob Agents 2015;45:444445.Google Scholar
7. Pillonetto, M, Arend, L, Vespero, EC, et al. First report of NDM-1-producing Acinetobacter baumannii sequence type 25 in Brazil. Antimicrob Agents Chemother 2014;58:75927594.Google Scholar
8. Carvalho-Assef, AP, Pereira, PS, Albano, RM, et al. Detection of NDM-1-, CTX-M-15-, and qnrB4-producing Enterobacter hormaechei isolates in Brazil. Antimicrob Agents Chemother 2014;58:24752476.CrossRefGoogle ScholarPubMed
9. Quiles, MG, Rocchetti, TT, Fehlberg, LC, et al. Unusual association of NDM-1 with KPC-2 and armA among Brazilian Enterobacteriaceae isolates. Braz J Med Biol Res 2015;48:174177.Google Scholar
10. Campos, JC, da Silva, MJ, Dos Santos, PR, et al. Characterization of Tn3000, a transposon responsible for bla NDM-1 dissemination among Enterobacteriaceae in Brazil, Nepal, Morocco, and India. Antimicrob Agents Chemother 2015;59:73877395.Google Scholar
Figure 0

TABLE 1 Phenotypic Characterization of Isolates and Transformants Obtained From NDM-1–Producers in Brazil